Cancer – Press Review – Revue de Presse
Every week on
http://marclacroixcancerblog.blogspot.com
Chaque semaine sur
http://marclacroixcancerblog.blogspot.com
Press Review (April 14, 2012) – Revue de presse (14 avril 2012)
Breast cancer mortality rates for African American women
disproportionately high
Last month, The Washington Post shared results of a new study
revealing that thousands of African American women are dying
needlessly from breast cancer because of psychosocial, cultural and
economic barriers. As the District’s only stand-alone cancer support
organization, we at Smith Center for Healing and the Arts applaud the
coverage of this important issue. The report’s timing however, is
ironic as funding for programs that directly address these disparities
is being dramatically reduced.
By Shanti Norris and Carole O’ Toole. In Washington Post (blog)
http://www.washingtonpost.com/blogs/therootdc/post/breast-cancer-mortality-rates-for-african-american-women-disproportionately-high/2012/04/09/gIQAxJoR6S_blog.html
Herbal Remedy Ingredient Tied to Cancer, Kidney Failure
Aristolochic acid is a potent human carcinogen found naturally in
botanical Asian remedies for aiding weight loss, easing joint pain and
improving stomach ailments.
In U.S. News & World Report
http://www.nydailynews.com/life-style/health/popular-herbal-remedy-blamed-high-urinary-tract-cancer-rate-taiwan-study-article-1.1060111?localLinksEnabled=false
Breast Cancer Treatment Side Effects May Last for Years
Study finds lingering pain, swelling, fatigue, mobility problems in
many women.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/04/11/breast-cancer-treatment-side-effects-may-last-for-years
Cancer Care Costs Higher in U.S. Than Europe, But Survival Longer
US cancer patients often live almost two years longer than similar
patients in Europe, arguing for the dollar value of care given,
researchers say.
By Steven Reinberg. In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/04/09/cancer-care-costs-higher-in-us-than-europe-but-survival-longer
Overtreatment in Cancer: Common Sense Medicine
Treatment for cancer has gotten out of hand. For almost every type of
cancer, there are now dozens of potential treatments, in what are
often hundreds of combinations. And, what is infinitely worse, these
treatments can be lined up one after the other in a seamless row so
that when one treatment fails, a doctor and patient simply step up to
the next one. It's gotten so that it's almost impossible to stop
treating cancer, because doing so means saying "no" to the next
treatment that is ready and waiting.
By David Casarett. In Huffington Post
http://www.huffingtonpost.com/david-casarett-md/cancer-treatment_b_1411993.html
Memory Problems After Cancer: 'Chemo Brain' May Not Be Sole Cause,
Study Suggests
There may be more than one factor responsible for "chemo brain" -- the
term used for memory and attention impairments often experienced after
undergoing chemotherapy for cancer, according to a small new study.
By Amanda L. Chan. In Huffington Post
http://www.huffingtonpost.com/2012/04/11/cancer-memory-problems_n_1418036.html
U.S. court invalidates two Sanofi Taxotere patents
A U.S. court has ruled that two patents covering Sanofi's Taxotere
cancer treatment are invalid, confirming a 2010 ruling that helped
pave the launch of generic versions of the drug.
In Reuters.
http://www.reuters.com/article/2012/04/10/sanofi-idUSL6E8FA4G720120410
Gene Discovery May Move Personalized Stomach Cancer Treatment Forward
Large analysis identified 600 gene mutations in cancerous cells.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/04/08/gene-discovery-may-move-personalized-stomach-cancer-treatment-forward
FDA Makes Plans to Correct Cancer-Drug Shortages in the US
Emergency efforts will keep the flow of lifesaving drugs to American
doctors.
By Alice G. Walton. In The Atlantic
http://www.theatlantic.com/health/archive/2012/04/fda-makes-plans-to-correct-cancer-drug-shortages-in-the-us/255661/
Short Walks May Ease Fatigue in Pancreatic Cancer Patients
Patients were told not to push themselves, but to do what they could
comfortably.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/04/10/short-walks-may-ease-fatigue-in-pancreatic-cancer-patients
Cancer: questions over proton beam therapy
The Government is to spend £250 million on a cutting edge cancer
treatment called proton beam therapy despite there being "no reliable,
objective evidence" that it improves patients' lives.
By Stephen Adams. In
Telegraph.co.uk
http://www.telegraph.co.uk/health/healthnews/9200870/Cancer-questions-over-proton-beam-therapy.html
New in Breast Cancer Treatments: Baking Soda and Spider Venom
Breast cancer patients have an overwhelming number of treatments
available to them these days, from surgery to hormone therapy to
chemotherapy. But new research is leading the quest for a cure in some
odd directions. If it pays off, the work could provide cancer
sufferers with a perfectly tailored -- if unconventional -- treatment
solution.
By Brian Fung. In The Atlantic
http://www.theatlantic.com/health/archive/2012/04/new-in-breast-cancer-treatments-baking-soda-and-spider-venom/255646/
Dentists Play Key Role in Detecting Oral Cancer
Ask for screening as part of your general checkup, experts say.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2012/04/07/dentists-play-key-role-in-detecting-oral-cancer
Taïwan : un traitement à base d'herbes mis en cause dans des cancers
Selon une récente étude américaine, un ingrédient toxique contenu dans
un traitement à base d'herbes très populaire serait responsable de
plus de la moitié des cas de cancer du système urinaire à Taïwan.
Dans MaxiSciences
http://www.maxisciences.com/cancer/taiwan-un-traitement-a-base-d-039-herbes-mis-en-cause-dans-des-cancers_art23549.html
Dépistage du cancer de la prostate: une utilité contestée
La Haute Autorité de santé réfute l'intérêt du test PSA, même pour les
hommes à risque.
Par Damien Mascret. Dans Le Figaro
http://sante.lefigaro.fr/actualite/2012/04/03/17916-depistage-cancer-prostate-utilite-contestee
Un lien entre les radiographies dentaires et les tumeurs au cerveau?
Des chercheurs de l'école de médecine de Yale, à New Haven, dans
l'État du Connecticut, ont découvert un lien entre les radiographies
dentaires et le cancer du cerveau.
Canoë
http://sante.canoe.com/channel_health_news_details.asp?news_id=6823&news_channel_id=31&channel_id=31
Cancer du sein : plus de 2,4 millions de femmes ont profité du
dépistage organisé en 2011
Quelque 2,4 millions de Françaises ont eu recours au dépistage
organisé du cancer du sein en 2011, soit près de 53% des femmes âgées
de 50 à 74 ans, population cible de ce dépistage, selon les dernières
données communiquées par l'Institut de veille sanitaire (InVS), jeudi
5 avril. Ce chiffre est quasiment stable par rapport aux données
observées en 2010.
Dans Le Parisien
http://www.leparisien.fr/laparisienne/sante/cancer-du-sein-plus-de-2-4-millions-de-femmes-ont-profite-du-depistage-organise-en-2011-05-04-2012-1942455.php
Les nanoparticules, ces molécules qui pourraient révolutionner le
traitement du cancer
Ces particules ont une taille infime, environ un 5000è du diamètre
d’un cheveu humain, et déchainent les passions. Selon une récente
étude, elles pourraient améliorer radicalement le traitement du
cancer. Mais elles inquiètent par leur omniprésence dans notre
environnement et leurs effets sur l'homme.
Dans Atlantico.fr
http://www.atlantico.fr/decryptage/nanoparticules-revolution-dans-traitement-cancer-326414.html
Congrès international d'oncologie à Bordj Bou Arréridj
Les conférenciers ont traité divers thèmes relatifs à cette maladie
dont les causes sont multiples: hérédité, tabagisme, alcoolisme,
absence d’activité physique...
Dans El Watan
http://www.elwatan.com/regions/est/actu-est/le-cancer-du-sein-et-du-poumon-en-debat-07-04-2012-165755_221.php
Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com
Marc Lacroix-Corman – InTextoResearch – Baelen (04/2012)